
Médico.Jefe del Servicio #Hematologia #Hemoterapia @hematologiaHGSE @Salud_JCYL Miembro de @SCLHH1 @sehh_es @EHA_Hematology @geltamo @_pethema
Segovia (Espańa)
Joined February 2014
- Tweets29.2K
- Following1.3K
- Followers1.4K
- Likes6.5K
Dr. José A. Queizán Hernández retweeted
#ASH26 #lymsm #DLBCL Real-world analysis of reduced dose polatuzumab vedotin-based regimens in the frontline setting in older or frail patients with large B-cell lymphoma onlineprogram.hematology.org…
Dr. José A. Queizán Hernández retweeted
"UN RAMITO DE VIOLETAS (1975)" 🎁
Quién la escribía versos dime quién era
Quién la mandaba flores por primavera
Quién cada nueve de noviembre
Como siempre sin tarjeta
La mandaba un ramito de violetas
#Cecilia🕯💐 #Noviembre9
Dr. José A. Queizán Hernández retweeted
“November Rain” - Guns N’ Roses
It became their biggest U.S. hit, peaking at #3 on the Billboard Hot 100. It’s one of the most iconic music videos ever made.
“We knew it was special. We just didn’t know it’d outlive us all.” - Duff
Dr. José A. Queizán Hernández retweeted
GUÍAS ASH 2026: TROMBOCITOPENIA INMUNE EN ADULTOS 🧵
➡️Tratamiento inicial y de segunda línea
📌Ya NO se sugiere esteroide solo como 1ª línea
✅Esteroide + rituximab o + agente trombopoyético
📍Algoritmo de tratamiento
doi: 10.1182/bloodadvances.2026021269
Newly diagnosed and relapsed follicular lymphoma: EHA Clinical Practice Guidelines for diagnosis, treatment, and follow‐up - Ladetto - 2026 - HemaSphere - Wiley Online Library onlinelibrary.wiley.com/doi/…
Dr. José A. Queizán Hernández retweeted
MIELOMA MÚLTIPLE: 2026
➡️Rajkumar; Am J Hematol
Elegible TCPH:
📌Inducción: Dara/Isa-VRd ➡️ TACPH
📌Mantenimiento: Lena + anti-CD38
✅Algoritmo tx de nuevo diagnóstico
💡Algoritmo tx en recaída
📍Alto riesgo IMS/IMWG y mSMART
📍Criterios dx IMWG
doi: 10.1002/ajh.70475
Dr. José A. Queizán Hernández retweeted
NEUTROPENIA AUTOINMUNE EN ADULTOS
➡️How I treat; Blood
📌+común en mujeres y con enf. autoinmunes
📌Ac anti-neutrófilo ➕ solo en ~50%
✅Algoritmo diagnóstico
💡Algoritmo terapéutico
📍Fisiopatología
📍Pruebas de Ac anti-neutrófilo
doi: 10.1182/blood.2025031311
Dr. José A. Queizán Hernández retweeted
Marginal zone lymphomas (MZL) pose a unique clinical challenge due to their marked heterogeneity across extranodal, nodal, and splenic subtypes.
📄 Read the full review: doi.org/10.3324/haematol.202…
Dr. José A. Queizán Hernández retweeted
See 2027 Annual Update on #follicular #lymphoma by Bret Wankel and @DrCarlaCasulo from @WilmotCancer just posted on @AjHematology
onlinelibrary.wiley.com/doi/…
Dr. José A. Queizán Hernández retweeted
Chemo-free beats R-GemOx on PFS. Phase 3 EPCORE DLBCL-4: epcoritamab+len (investigational in DLBCL) vs R-GemOx, ASCT/CAR-T ineligible. PFS HR 0.40, mPFS 16.5 vs 3.4 mo, CR 51% vs 28%. OS immature. @Genmab @abbvie #ASH26 #lymsm onlineprogram.hematology.org…
Dr. José A. Queizán Hernández retweeted
ASH has established new reference ranges for individuals with Duffy-null status, helping clinicians interpret blood counts more accurately and reduce unnecessary testing and treatment interruptions. ow.ly/b3Zm5104hvh
Dr. José A. Queizán Hernández retweeted
When should I order the serum
free light-chain assay, and how
should I interpret mild kappa
or lambda elevations
ccjm.org/content/93/8/459
Dr. José A. Queizán Hernández retweeted
Management of advanced mycosis fungoides and Sézary Syndrome: International Recommendations
@AnnaSureda5
onlinelibrary.wiley.com/doi/…
Dr. José A. Queizán Hernández retweeted
Follicular lymphoma 2027 • ANNUAL CLINICAL UPDATES IN HEMATOLOGICAL MALIGNANCIES
onlinelibrary.wiley.com/doi/…
@AjHematology
Dr. José A. Queizán Hernández retweeted
ASH 2026 abstract is now open!! onlineprogram.hematology.org…
Dr. José A. Queizán Hernández retweeted
“Take Five” is like a sophisticated jazz cocktail in a 1960s café.
Dr. José A. Queizán Hernández retweeted
🔬 ¿Qué es una PET-TAC y para qué sirve?
El especialista en Medicina Nuclear Javier Gómez explica en "Tu Salud al Día" cómo funciona esta prueba, qué información aporta y cómo es el recorrido del paciente.
🔗 youtube.com/watch?v=SrIyn0uJ…
#Sacyl #EscuelaDePacientes #TuSaludAlDía



























